Current Pain and Headache Reports

, Volume 16, Issue 5, pp 423–432 | Cite as

Myofascial Low Back Pain

  • Ryan R. Ramsook
  • Gerard A. MalangaEmail author
Myofascial Pain (RD Gerwin, Section editor)


Low back pain is a common condition that is encountered by both primary care physicians as well as various specialists, which include: orthopedic surgeons, physical medicine and rehabilitation specialists, neurologists, rheumatologists, and pain management specialists. Associated muscular pain is very common and often a reactive response from nociception from other structures. Myofascial pain may arise, which is characterized by the presence of myofascial trigger points (MTrPs) that are located in fascia, tendons, and/or muscle. This article reviews the current evidence regarding the pathophysiology, assessment, and recommended treatment options for myofascial low back pain.


Low back pain Myofascial Muscular Trigger points 



No potential conflicts of interest relevant to this article were reported.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Fishbain DA, Goldberg M, Meagher BR, et al., Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria. Pain. 26:181–97.Google Scholar
  2. 2.
    Tough EA, White AR, Richards S, Campbell J. Variability of criteria used to diagnose myofascial trigger point pain syndrome–evidence from a review of the literature. Clin J Pain. 2007;23:278–86.PubMedCrossRefGoogle Scholar
  3. 3.
    Partanen JV, Ojala TA, Arokoski JP. Myofascial syndrome and pain: a neurophysiological approach. Pathophysiology. 2010;17:19–28.PubMedCrossRefGoogle Scholar
  4. 4.
    Simons DG. New views of myofascial trigger points: etiology and diagnosis. Arch Phys Med Rehabil. 2008;89:157–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Simons DG, Travell JG, Simons LS. Travell & Simons’ myofascial pain and dysfunction: the trigger point manual. Pennsylvania: Williams & Wilkins; 1999.Google Scholar
  6. 6.
    Kuan TS, Hong CZ, Chen JT, et al. The spinal cord connections of the myofascial trigger spots. Eur J Pain. 2007;11:624–34.PubMedCrossRefGoogle Scholar
  7. 7.
    Shah JP, Gilliams EA. Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome. J Bodyw MovTher. 2008;12:371–84.CrossRefGoogle Scholar
  8. 8.
    Shah JP, Danoff JV, Desai MJ, et al. Biochemicals associated with pain and inflammation are elevated in sites near to, and remote from active myofascial trigger points. Arch Phys Med Rehabil. 2008;89:16–23.PubMedCrossRefGoogle Scholar
  9. 9.
    Hong CZ, Simons DG. Pathophysiologic and electrophysiologic mechanisms of myofascial trigger points. Arch Phys Med Rehabil. 1998;79:863–72.PubMedCrossRefGoogle Scholar
  10. 10.
    McPartland JM. Travell trigger points–molecular and osteopathic perspectives. J Am Osteopath Assoc. 2004;104:244–9.PubMedGoogle Scholar
  11. 11.
    Gerwin RD. The taut band and other mysteries of the trigger point: an examination of the mechanisms relevant to the development and maintenance of the trigger point. J Musculoskeletal Pain. 2008;16:115–21.CrossRefGoogle Scholar
  12. 12.
    • Staud R. Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep. 2011;13:513–20. The author attempts to decipher the pain mechanisms involved with the common chronic pain disorders of low back pain, osteoarthritis, and fibromyalgia. The author states that abnormal processing of peripheral tissue impulse play an important role in all 3 disorders. Central sensitization can occur in all 3 disorders and may be due to input from the brainstem to the spinal cord through descending pain pathways. These pathways can cause dorsal horn neuron excitability leading to ineffective pain control. Both ineffective endogenous pain control and central sensitization are important features of osteoarthritis, low back pain and fibromyalgia. These findings help to add to the body of knowledge concerning pain mechanisms in these 3 chronic pain disorders.PubMedCrossRefGoogle Scholar
  13. 13.
    Marcus DA. Duloxetine use in painful conditions. Expert Opin Pharmacother. 2011;12:1333–40.PubMedCrossRefGoogle Scholar
  14. 14.
    •• Xu YM, Ge HY, Arendt-Nielsen L. Sustained nociceptive mechanical stimulation of latent myofascial trigger point induces central sensitization in healthy subjects. J Pain. 2010;11:1348–55. The authors found that nociceptive mechanical stimulation of latent myofascial trigger points induced widespread mechanical hyperalgesia and that muscle cramping induced both local and referred pain as evidenced through EMG readings and subjective pain. These findings show that trigger points are a crucial component in generating pain as well as inducing central sensitization. Treatments aimed at decreasing trigger point sensitivity and motor-unit excitability may decrease muscle cramping and consequently local and referred pain.PubMedGoogle Scholar
  15. 15.
    Chen WK, Liu IY, Chang YT, et al. Ca(v)3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain. J Neurosci. 2010;30:10360–8. PubMedCrossRefGoogle Scholar
  16. 16.
    Mense S. Referral of muscle pain. J Am Phys Soc. 1994;3:1–9.Google Scholar
  17. 17.
    Gerwin RD. A review of myofascial pain and fibromyalgia–factors that promote their persistence. Acupuncture Med. 2005;23:121–34.CrossRefGoogle Scholar
  18. 18.
    Majlesi J, Unalan H. Effect of treatment on trigger points. Curr Pain Headache Rep. 2010;14:353–60.PubMedCrossRefGoogle Scholar
  19. 19.
    Friedrich M, Hahne J, Wepner F. A controlled examination of medical and psychosocial factors associated with low back pain in combination with widespread musculoskeletal pain. Phys Ther. 2009;89:786–803.PubMedCrossRefGoogle Scholar
  20. 20.
    Malanga GA. Myofascial low back pain: a review. Phys Med Rehabil Clin N Am. 2010;21:711–24.PubMedCrossRefGoogle Scholar
  21. 21.
    Myburgh C, Lauridsen HH, Larsen AH, Hartvigsen J. Standardized manual palpation of myofascial trigger points in relation to neck/shoulder pain; the influence of clinical experience on inter-examiner reproducibility. Man Ther. 2011;16:136–40.PubMedCrossRefGoogle Scholar
  22. 22.
    Lucas N, Macaskill P, Irwig L, et al. Reliability of physical examination for diagnosis of myofascial trigger points: a systematic review of the literature. Clin J Pain. 2009;25:80–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Vedolin GM, Lobato VV, Conti PC, Lauris JR, et al. The impact of stress and anxiety on the pressure pain threshold of myofascial pain patients. J Oral Rehabil. 2009;36:313–21.PubMedCrossRefGoogle Scholar
  24. 24.
    Chien JJ, Bajwa ZH. What is mechanical back pain and how best to treat it? Curr Pain Headache Rep. 2008;12:406–11.PubMedCrossRefGoogle Scholar
  25. 25.
    Edwards J. The importance of postural habits in perpetuating myofascial trigger point pain. Acupuncture Med. 2005;23:77–82.CrossRefGoogle Scholar
  26. 26.
    Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clinic proceedings. Mayo Clinic Proc. 2003;78:1463–70.CrossRefGoogle Scholar
  27. 27.
    Mense S, Simons DG, Russell IJ. Muscle pain. Understanding its nature, diagnosis, and treatment. Baltimore, MD: Lippincott Williams and Wilkins; 2001.Google Scholar
  28. 28.
    Arnold LM, McCarberg BH. Improving the recognition and diagnosis of fibromyalgia. Mayo Clinic Proc. 2011;86:457–64.CrossRefGoogle Scholar
  29. 29.
    Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160–72.PubMedCrossRefGoogle Scholar
  30. 30.
    Wolfe F, Rasker JJ. The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms. J Rheumatol. 2006;33:2291–9.PubMedGoogle Scholar
  31. 31.
    Bengtsson A, Henriksson KG, Jorfeldt L, et al. Primary fibromyalgia. A clinical and laboratory study of 55 patients. Scand J Rheumatol. 1986;15:340–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Wolfe F, Simons DG, Fricton J, et al. The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease. J Rheumatol. 1992;19:944–51.PubMedGoogle Scholar
  33. 33.
    Ge HY, Wang Y, Danneskiold-Samsoe B, et al. The predetermined sites of examination for tender points in fibromyalgia syndrome are frequently associated with myofascial trigger points. J Pain. 2010;11:644–51.PubMedCrossRefGoogle Scholar
  34. 34.
    Giamberardino MA, Affaitati G, Fabrizio A, Constantini R. Myofascial pain syndromes and their evaluation. Best practice and research. Clin Rheumatol. 2011;25:185–98.Google Scholar
  35. 35.
    Srbely JZ. New trends in the treatment and management of myofascial pain syndrome. Curr Pain Headache Rep. 2010;14:346–52.PubMedCrossRefGoogle Scholar
  36. 36.
    Maigne JY, Cornelis P, Chatellier G. Lower back pain and neck pain: is it possible to identify the painful side by palpation only? Ann Phys Rehabil Med. 2012;55:103–11.PubMedGoogle Scholar
  37. 37.
    Malanga G, Wolff E. Evidence-informed management of chronic low back pain with trigger point injections. Spine J. 2008;8:243–52.PubMedCrossRefGoogle Scholar
  38. 38.
    Sikdar S, Shah JP, Gilliams E, et al. Assessment of myofascial trigger points (MTrPs): a new application of ultrasound imaging and vibration sonoelastography. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Eng Med Biol Soc Conf. 2008;2008:5585–8.Google Scholar
  39. 39.
    Muthupillai R, Lomas DJ, Rossman PJ, et al. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science. 1995;269:1854–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Magnetic resonance elastography: an overview. Available from: Accessed March 2012.
  41. 41.
    Chen Q, Bensamoun S, Basford JR, et al. Identification and quantification of myofascial taut bands with magnetic resonance elastography. Arch Phys Med Rehabil. 2007;88:1658–61.PubMedCrossRefGoogle Scholar
  42. 42.
    Chen Q, Basford J, An KN. Ability of magnetic resonance elastography to assess taut bands. Clin Biomech. 2008;23:623–9.CrossRefGoogle Scholar
  43. 43.
    Sikdar S, Shah JP, Gebreab T, et al. Novel applications of ultrasound technology to visualize and characterize myofascial trigger points and surrounding soft tissue. Arch Phys Med Rehabil. 2009;90:1829–38.PubMedCrossRefGoogle Scholar
  44. 44.
    Hunter C, Dubois M, Zou S, et al. A new muscle pain detection device to diagnose muscles as a source of back and/or neck pain. Pain Med. 2010;11:35–43.PubMedCrossRefGoogle Scholar
  45. 45.
    Hong CZ. Treatment of myofascial pain syndrome. Curr Pain Headache Rep. 2006;10:345–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Phys. 2002;65:653–60.Google Scholar
  47. 47.
    Han SC, Harrison P. Myofascial pain syndrome and trigger-point management. Reg Anesth. 1997;22:89–101.PubMedCrossRefGoogle Scholar
  48. 48.
    Wong CK. Strain counterstrain: current concepts and clinical evidence. Man Ther. 2012;17:2–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Hsieh RL, Lee WC. Are the effects of botulinum toxin injection on myofascial trigger points placebo effects or needling effects? Arch Phys Med Rehabil. 2008;89:792–3. author reply 793.PubMedCrossRefGoogle Scholar
  50. 50.
    •• Bhandary AK, Chimes GP, Ma’langa GA. Investigational pharmacology for low back pain. J Pain Res. 2010;3:169–81. A diverse population as well as treating pain that is maintained with neuropathic and nociceptive mechanisms along with central, and peripheral pathways, creates a therapeutic challenge that may need a multimodal approach to be effective. The authors showcase many novel drugs in various clinical stages that may change the way in which low back pain is treated. Various current and emerging drugs are discussed including ion channel blockers, cannabinoids, cannabinoid receptor agonists, antidepressants, B-mimetics, botulinum toxin, opiods, prostanoids, and salmon calcitonin. These drug therapies may change treatment of low back pain in the future.PubMedGoogle Scholar
  51. 51.
    Bias P, Buchner A, Klesser B, Laufer S. The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial. Am J Gastroenterol. 2004;99:611–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Rordorf CM, Choi L, Marshall P, Mangold JB, et al. Clin Pharmacokinet. 2005;44:1247–66.PubMedCrossRefGoogle Scholar
  53. 53.
    Leite FM, Atallah AN, El Dib R, et al. Cyclobenzaprine for the treatment of myofascial pain in adults. Cochrane Database Syst Rev. 2009; Issue 3. Art. No.:CD006830. doi: 10.1002/14651858.CD006830.pub3.
  54. 54.
    Vazquez-Delgado E, Cascos-Romero J, Gay-Escoda C. Myofascial pain associated to trigger points: a literature review. Part 2: differential diagnosis and treatment. Medicina Oral, Patologia Oral Y Cirugia Bucal. 2010;15:e639–43.PubMedCrossRefGoogle Scholar
  55. 55.
    Yalcin I, Tessier LH, Petit-Demouliere N, et al. Beta2-adrenoceptors are essential for desipramine, venlafaxine, or reboxetine action in neuropathic pain. Neurobiol Dis. 2009;33:386–94.PubMedCrossRefGoogle Scholar
  56. 56.
    Yalcin I, Choucair-Jaafar N, Benbouzid M, et al. Beta(2)-adrenoceptors are critical for antidepressant treatment of neuropathic pain. Ann Neurol. 2009;65:218–25.PubMedCrossRefGoogle Scholar
  57. 57.
    Ay S, Evcik D, Tur BS. Comparison of injection methods in myofascial pain syndrome: a randomized controlled trial. Clin Rheumatol. 2010;29:19–23.PubMedCrossRefGoogle Scholar
  58. 58.
    Hong CZ. Lidocaine injection vs dry needling to myofascial trigger point. The importance of the local twitch response. Association of Academic Physiatrists. Am J Phys Med Rehabil. 1994;73:256–63.PubMedCrossRefGoogle Scholar
  59. 59.
    Scott NA, Guo B, Barton PM, Gerwin RD. Trigger point injections for chronic non-malignant musculoskeletal pain: a systematic review. Pain Med. 2009;10:54–69.PubMedCrossRefGoogle Scholar
  60. 60.
    Hameroff SR, Crago BR, Blitt CD, et al. Comparison of bupivacaine, etidocaine, and saline for trigger-point therapy. Anesth Analg. 1981;60:752–5.PubMedCrossRefGoogle Scholar
  61. 61.
    Garvey TA, Marks MR, Wiesel SW. A prospective, randomized, double-blind evaluation of trigger-point injection therapy for low-back pain. Spine. 1989;14:962–4.PubMedCrossRefGoogle Scholar
  62. 62.
    Hong CZ. Response to treatment for pectoralis minor myofascial pain syndrome after whiplash. J Musculoskeletal Pain. 1992;1:89–132.CrossRefGoogle Scholar
  63. 63.
    Reilich P, Fheodoroff K, Kern U, et al. Consensus statement: botulinum toxin in myofascial [corrected] pain. J Neurol. 2004;251 Suppl 1:I36–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Borodic GE, Acquadro M, Johnson EA. Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects. Expert Opin Investig Drug. 2001;10:1531–44.CrossRefGoogle Scholar
  65. 65.
    Gobel H, Heinze A, Reichel G, et al. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Pain. 2006;125:82–8.PubMedCrossRefGoogle Scholar
  66. 66.
    • De Andres J, Adsuara VM, Palmisani S, et al. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans. Reg Anesth Pain Med. 2010;35:255–60. Botulinum toxin therapy in muscles commonly associated with myofascial low back pain, iliopsoas, and/or quadratus lumborum, showed similar pain relief as with treatment with NaCl or bupivacaine. Due to the high cost of BTX-A and comparable efficacy with control treatments, its use should be limited to refractory pain.PubMedCrossRefGoogle Scholar
  67. 67.
    Wheeler AH, Goolkasian P, Gretz SS. Botulinum toxin A for the treatment of chronic neck pain. Pain. 2001;94:255–60.PubMedCrossRefGoogle Scholar
  68. 68.
    Wheeler AH, Goolkasian P, Gretz SS. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine. 1998;23:1662–6. discussion 1667.PubMedCrossRefGoogle Scholar
  69. 69.
    Shafer N. Pneumothorax following “trigger point” injection. JAMA. 1970;213:1193.PubMedCrossRefGoogle Scholar
  70. 70.
    Peloso P, Gross A, Haines T, et al. Medicinal and injection therapies for mechanical neck disorders. Cochrane Database Syst Rev. J Rheumatol. 2006;33;957–967.Google Scholar
  71. 71.
    Ferrante FM, Bearn L, Rothrock R, King L. Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type A. Anesthesiology. 2005;103:377–83.PubMedCrossRefGoogle Scholar
  72. 72.
    Furlan AD, van Tulder M, Cherkin D, et al. Acupuncture and dry-needling for low back pain: an updated systematic review within the framework of the cochrane collaboration. Spine. 2005;30:944–63.PubMedCrossRefGoogle Scholar
  73. 73.
    Itoh K, Katsumi Y, Hirota S, Kitakoji H. Effects of trigger point acupuncture on chronic low back pain in elderly patients–a sham-controlled randomized trial. Acupuncture Med. 2006;24:5–12.CrossRefGoogle Scholar
  74. 74.
    Melzack R, Stillwell DM, Fox EJ. Trigger points and acupuncture points for pain: correlations and implications. Pain. 1977;3:3–23.PubMedCrossRefGoogle Scholar
  75. 75.
    Gazi MC, Issy AM, Avila IP, Sakata RK. Comparison of acupuncture to injection for myofascial trigger point pain. Pain Pract. 2011;11:132–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Srbely JZ, Dickey JP, Lowerison M, et al. Stimulation of myofascial trigger points with ultrasound induces segmental antinociceptive effects: a randomized controlled study. Pain. 2008;139:260–6.PubMedCrossRefGoogle Scholar
  77. 77.
    Srbely JZ, Dickey JP. Randomized controlled study of the antinociceptive effect of ultrasound on trigger point sensitivity: novel applications in myofascial therapy? Clin Rehabil. 2007;21:411–7.PubMedCrossRefGoogle Scholar
  78. 78.
    Vernon H, Schneider M. Chiropractic management of myofascial trigger points and myofascial pain syndrome: a systematic review of the literature. J Manip Physiol Therapeut. 2009;32:14–24.CrossRefGoogle Scholar
  79. 79.
    • Koo TK, Cohen JH, Zheng Y. Immediate effect of nimmo receptor tonus technique on muscle elasticity, pain perception, and disability in subjects with chronic low back pain. J Manip Physiol Therapeut. 2012;35:45–53. Full Nimmo receptor tonus technique treatment on prominent gluteus medius trigger points showed significant improvement in subject pain and disability as well as a greater decrease in muscle tone and electrogenic spasm. This technique may be more beneficial than focal trigger point treatment.CrossRefGoogle Scholar
  80. 80.
    Standaert CJ, Friedly J, Erwin MW, et al. Comparative effectiveness of exercise, acupuncture, and spinal manipulation for low back pain. Spine. 2011;36(Suppl):S120–30.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Physical Medicine and RehabilitationUMDNJ- New Jersey Medical SchoolNewarkUSA
  2. 2.Overlook Pain CenterSummitUSA
  3. 3.Department of Physical Medicine and RehabilitationUMDNJ- New Jersey Medical SchoolNewarkUSA

Personalised recommendations